IGM is doing so after imvotamab failed to deplete B cell counts — its therapeutic goal — as effectively as the company had hoped in early-stage tests in rheumatoid arthritis and lupus.
Oral fluid antibody responses were assessed with a ... The Cellex quantitative (q)SARS-CoV-2 IgG/IgM Rapid test, a low-cost POC test, was also evaluated. Negative results from the Rapid test ...
Total means the test detects both types of antibodies that occur in response to HAV, including immunoglobulin M (IgM) and immunoglobulin G (IgG) antibodies. A total reactive result means the HAV ...
both IgM-based bispecific antibody T cell engagers, for autoimmune diseases. Imvotamab or CD20 x CD3 is a bispecific IgM antibody that targets CD20 and CD3 proteins. It has 10 binding units for ...